Acadia Healthcare Company, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 01:00 PM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Brent Turner, President, Joey A. Jacobs, Chairman and Chief Executive Officer.

Acadia Healthcare Company, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. Revenue increased 80.0% for the first quarter to $161.2 million from $89.6 million for the first quarter of 2012. Income from continuing operations was $4.1 million, or $0.08 per diluted share, for the first quarter of 2013 compared with $3.3 million, or $0.10 per diluted share, for the first quarter of 2012. Adjusted income from continuing operations increased 178.9% to $10.6 million for the first quarter of 2013 from $3.8 million for the first quarter of 2012. The adjusted results for the first quarter of 2013 exclude debt extinguishment costs of $9.4 million and transaction-related expenses of $1.5 million and, for the first quarter of 2012, exclude transaction-related expenses of $0.7 million. Adjusted income from continuing operations per diluted share increased 75.0% to $0.21 for the first quarter of 2013 from $0.12 for the first quarter of 2012, which reflected a 55.4% increase in weighted average shares outstanding for the comparable quarters, primarily due to Acadia's public equity offerings in May 2012 and December 2012. Income from continuing operations before income taxes was $6.7 million against $5 million a year ago. Net income was $3.7 million or $0.07 per basic and diluted share against $3.7 million or $0.11 per basic and diluted share a year ago. Net cash provided by operating activities was $0.2 million against $4.9 million a year ago. Cash paid for capital expenditures were $12.8 million against $3.9 million a year ago. EBITDA was $19.1 million against $13.9 million a year ago. Adjusted EBITDA was $30.5 million against $15.2 million a year ago. The company increased its guidance for 2013 adjusted earnings per diluted share to a range of $1.00 to $1.03 from the prior range of $0.96 to $1.00. The company expects to have positive, a more healthier cash flow from operations in the subsequent quarters. The company will also support future growth through the remainder of 2013 by adding new beds to existing facilities, with a total of approximately 300 beds planned for the year. The company will continue to excess capacity at all facilities, with the goal of adding new beds before they are needed. To achieve this goal, the company expects to increase beds in existing facilities by at least 5% on an annual basis.

Acadia Healthcare Company, Inc., Q1 2013 Earnings Call, May 02, 2013